Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Toxicol Lett ; 213(2): 135-41, 2012 Sep 03.
Artículo en Inglés | MEDLINE | ID: mdl-22750881

RESUMEN

A high-fat (HF) diet, the serotonergic system and stromal elements have all been implicated in colon carcinogenesis. We investigated whether the colonic serotonergic system could play a main role in the development of colonic dysplasia and stromal reactivity in carcinogen-treated rats under HF diet. For this, dimethylhydrazine-treated rats were fed with standard diet and a HF diet. Fat distribution was quantified by computerized tomography exam, serotonergic activity was analyzed by high-performance liquid chromatography, gene expression, and immunohistochemistry, which along with histopathological technique enabled us to enumerate dysplasia, microvessels density, cell proliferation and COX-2 expression. We found that the HF diet induced an increase in the amount of visceral adipose tissue, even without expressive changes in the average body weight. This was correlated with a loss of serotonergic balance in colon tissue. Moreover, the HF diet promoted dysplasia and microvessel density in association with increased proliferation and COX-2 expression within pericryptal colonic stroma. Our current findings suggest that a HF diet promotes the enlargement of adipose tissue via loss of control in colon serotonergic activity, which enhances colonic dysplasia by supporting microvessel development.


Asunto(s)
Neoplasias del Colon/metabolismo , Neoplasias del Colon/patología , Dieta Alta en Grasa/efectos adversos , Grasa Intraabdominal/metabolismo , Grasa Intraabdominal/patología , Serotonina/metabolismo , Animales , Ciclooxigenasa 2/metabolismo , Grasas de la Dieta/administración & dosificación , Femenino , Ácido Hidroxiindolacético/metabolismo , Inmunohistoquímica , Grasa Intraabdominal/enzimología , Masculino , ARN/química , ARN/genética , Distribución Aleatoria , Ratas , Ratas Wistar , Reacción en Cadena en Tiempo Real de la Polimerasa
2.
Toxicol Lett ; 204(2-3): 134-40, 2011 Jul 28.
Artículo en Inglés | MEDLINE | ID: mdl-21554931

RESUMEN

Fluoxetine (FLX) is a drug commonly used as antidepressant. However, its effects on tumorigenesis remain controversial. Aiming to evaluate the effects of FLX treatment on early malignant changes, we analyzed serotonin (5-HT) metabolism and recognition, aberrant crypt foci (ACF), proliferative process, microvessels, vascular endothelial growth factor (VEGF), and cyclooxygenase-2 (COX-2) expression in colon tissue. Male Wistar rats received a daily FLX-gavage (30mgkg(-1)) and, a single dose of 1,2 dimethylhydrazine (DMH; i.p., 125mgkg(-1)). After 6 weeks of FLX-treatment, our results revealed that FLX and nor-fluoxetine (N-FLX) are present in colon tissue, which was related to significant increase in serotonin (5-HT) levels (P<0.05) possibly through a blockade in SERT mRNA (serotonin reuptake transporter; P<0.05) resulting in lower 5-hydroxyindoleacetic acid (5-HIAA) levels (P<0.01) and, 5-HT2C receptor mRNA expressions. FLX-treatment decreased dysplastic ACF development (P<0.01) and proliferative process (P<0.001) in epithelia. We observed a significant decrease in the development of malignant microvessels (P<0.05), VEGF (P<0.001), and COX-2 expression (P<0.01). These findings suggest that FLX may have oncostatic effects on carcinogenic colon tissue, probably due to its modulatory activity on 5-HT metabolism and/or its ability to reduce colonic malignant events.


Asunto(s)
Neoplasias del Colon/prevención & control , Fluoxetina/farmacología , Inhibidores Selectivos de la Recaptación de Serotonina/farmacología , Animales , Proliferación Celular , Colon/efectos de los fármacos , Colon/metabolismo , Ciclooxigenasa 2/análisis , Masculino , Lesiones Precancerosas/prevención & control , Ratas , Ratas Wistar , Serotonina/metabolismo , Factor A de Crecimiento Endotelial Vascular/análisis
3.
Biochem Biophys Res Commun ; 405(4): 593-8, 2011 Feb 25.
Artículo en Inglés | MEDLINE | ID: mdl-21266165

RESUMEN

Constant light (LL) is associated with high incidence of colon cancer. MLT supplementation was related to the significant control of preneoplastic patterns. We sought to analyze preneoplastic patterns in colon tissue from animals exposed to LL environment (14 days; 300 lx), MLT-supplementation (10mg/kg/day) and DMH-treatment (1,2 dimethylhydrazine; 125 mg/kg). Rodents were sacrificed and MLT serum levels were measured by radioimmunoassay. Our results indicated that LL induced ACF development (p < 0.001) with a great potential to increase the number of CD133(+) and CD68(+) cells (p < 0.05 and p < 0.001). LL also increased the proliferative process (PCNA-Li; p < 0.001) as well as decreased caspase-3 protein (p < 0.001), related to higher COX-2 protein expression (p < 0.001) within pericryptal colonic stroma (PCCS). However, MLT-supplementation controlled the development of dysplastic ACF (p < 0.001) diminishing preneoplastic patterns into PCCS as CD133 and CD68 (p < 0.05 and p < 0.001). These events were relative to decreased PCNA-Li index and higher expression of caspase-3 protein. Thus, MLT showed a great potential to control the preneoplastic patterns induced by LL.


Asunto(s)
Neoplasias del Colon/etiología , Neoplasias del Colon/prevención & control , Luz/efectos adversos , Melatonina/administración & dosificación , Células Madre Neoplásicas/efectos de los fármacos , Animales , Colon/efectos de los fármacos , Colon/metabolismo , Colon/patología , Colon/efectos de la radiación , Neoplasias del Colon/patología , Masculino , Melatonina/sangre , Melatonina/fisiología , Células Madre Neoplásicas/metabolismo , Células Madre Neoplásicas/patología , Ratas , Ratas Wistar , Células del Estroma/efectos de los fármacos , Células del Estroma/metabolismo , Células del Estroma/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA